Bioorganic and Medicinal Chemistry Letters p. 1403 - 1406 (2019)
Update date:2022-08-03
Topics:
Ruparelia, Ketan C.
Lodhi, Sabahat
Ankrett, Dyan N.
Wilsher, Nicola E.
Arroo, Randolph R.J.
Potter, Gerard A.
Beresford, Kenneth J.M.
As part of a programme to develop anticancer prodrugs which are activated by cytochrome P450 (CYP)1B1, a library of 4,6-diaryl-2-pyridones was synthesised in yields of 6–60% from the corresponding chalcones. A number of these derivatives showed promising antiproliferative activities in human breast cancer cell lines which express CYP1B1 and CYP1A1, while showing little toxicity towards a non-tumour breast cell line with no CYP expression. Metabolism studies provided evidence supporting the involvement of CYP1 enzymes in the bioactivation of these compounds.
View MoreContact:+86-10-59484199
Address:No.58-A1026 Liangguan Street
Shanghai He Yang International Trading Co., Ltd.
Contact:+86-21-52043598
Address:Room 816, Blag.5, No.58 Huachi Road
website:http://www.simagchem.com
Contact:+86-592-2680277
Address:21/F Hualong Office Building,No.6 Hubin East Road, Xiamen,China
Beijing Cooperate Pharmaceutical Co.,Ltd
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
website:http://www.china-sinoway.com
Contact:+86-592-5853819
Address:16/F,Huicheng Comm,Complex,No839 XiaHe Rd, Xiamen,China
Doi:10.3987/COM-09-11746
(2009)Doi:10.1021/om900701n
(2009)Doi:10.1016/j.bmc.2009.09.042
(2009)Doi:10.1016/j.ejmech.2009.06.013
(2009)Doi:10.1016/j.tet.2017.03.089
(2017)Doi:10.1002/anie.201410268
(2015)